Cephalexin Prophylaxis for Recurrent UTI in Children
For children with recurrent urinary tract infections, cephalexin prophylaxis at 12.5-15 mg/kg once daily at bedtime is an effective and well-tolerated option, though current evidence suggests prophylaxis should be reserved for high-risk patients rather than used routinely.
Eligibility Criteria for Prophylaxis
The decision to initiate continuous antibiotic prophylaxis (CAP) should be risk-stratified rather than universal 1:
- High-risk candidates include children with high-grade vesicoureteral reflux (VUR grades III-V), bilateral VUR, bladder and bowel dysfunction (BBD), age <12 months at first febrile UTI, and uncircumcised males 1
- Low-grade VUR (grades I-II) shows minimal or no benefit from prophylaxis 1
- Recent evidence demonstrates that prophylaxis prevents approximately 1 UTI for every 7 children treated over 2 years, without reducing kidney scarring or long-term renal complications 1
Recommended Dosing Regimen
Cephalexin Prophylactic Dose
- 12.5-15 mg/kg once daily at bedtime 2
- Alternate-night dosing (same dose) shows equivalent efficacy with potentially lower cost 2
- Maximum dose typically 250 mg nightly 3, 4
Alternative Prophylactic Agents
First-line alternatives:
- Trimethoprim-sulfamethoxazole (TMP-SMX): Most commonly recommended, but avoid in infants <6 weeks due to hepatic injury risk and in severe renal insufficiency 1
- Nitrofurantoin: Avoid before age 4 months due to hemolytic anemia risk 1
- Amoxicillin: Another acceptable option 1
For penicillin-allergic patients:
- Cephalexin remains an option unless there is immediate-type hypersensitivity 5
- TMP-SMX or nitrofurantoin are suitable alternatives 1
- Other cephalosporins (cefadroxil, cefaclor, cefixime) have demonstrated efficacy 2, 6, 7
Duration of Prophylaxis
- Continue until BBD resolution when bladder dysfunction is present 1
- Minimum 1 year after last febrile UTI to reduce recurrence risk 1
- Patients receiving prophylaxis <1 year after last UTI and those with bilateral VUR have higher recurrence rates 1
- Typical study durations range from 6-12 months 2, 6, 7
Treatment Dosing (Acute UTI)
When treating acute UTI rather than prophylaxis, cephalexin dosing differs significantly 5, 8:
Pediatric treatment dose:
- 50-100 mg/kg/day divided every 6 hours (four times daily) 5
- For streptococcal pharyngitis and skin infections, may divide every 12 hours 8
- Duration: 7-14 days for febrile UTI 5
Adult treatment dose:
- 500 mg every 6 hours or 1000 mg every 12 hours for uncomplicated cystitis 8
- Recent evidence suggests 500 mg twice daily may be as effective as four-times-daily dosing for uncomplicated UTI 9
Important Caveats and Monitoring
Resistance Considerations
- Local resistance patterns must guide antibiotic selection, particularly for TMP-SMX and cephalexin 5
- Low-dose cephalexin prophylaxis (250 mg nightly) does not induce resistance in fecal/vaginal E. coli flora 3
- Breakthrough UTIs on prophylaxis may involve non-E. coli organisms with increased antibiotic resistance 1
When to Discontinue Prophylaxis
- Breakthrough febrile UTI despite prophylaxis warrants consideration of surgical intervention rather than continued medical management 1
- Switch to alternative antibiotic if breakthrough occurs, guided by culture susceptibilities when available 1
Contraindications
- Cephalexin should not be used as monotherapy for febrile UTI/pyelonephritis in young infants requiring parenteral therapy 5
- Nitrofurantoin is inappropriate for febrile UTI as it does not achieve adequate serum/parenchymal concentrations 5
Comparative Effectiveness
- Cephalexin prophylaxis shows 78-80% effectiveness in preventing recurrent UTI 2
- Efficacy is comparable to other prophylactic agents including cefadroxil, cefaclor, cefixime, and nitrofurantoin 2, 6, 7
- For acute treatment, cephalexin demonstrates similar outcomes to cefdinir and TMP-SMX, though cefdinir may require fewer medication changes 10
Practical Considerations
- Cephalexin suspension must be refrigerated after mixing and remains stable for 14 days 8
- Postcoital prophylaxis (250 mg single dose) is highly effective in sexually active women, using only one-third the tablets of daily regimens 4
- Drug interactions: Monitor metformin closely as cephalexin increases metformin levels by 24-34% 8